Files
2026-07-06 17:27:20 -04:00

12 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Pharmacy matters. Provides that a state employee plan, a health maintenance organization, an insurer, or a pharmacy benefits manager (health plan provider) may not require a pharmacy or pharmacist to collect a higher copayment for a prescription drug from a covered individual than the health plan provider allows the pharmacy or pharmacist to retain. Allows a pharmacist who meets certain requirements to dispense auto-injectable epinephrine by standing order to a person who: (1) has completed a course on auto-injectable epinephrine; and (2) is an individual in a position to assist an individual who is at risk of experiencing anaphylaxis. Allows a person to administer auto-injectable epinephrine to an individual who is experiencing anaphylaxis if certain conditions are met. Requires the state department of health (state department) to issue a statewide standing order authorizing the dispensing of auto-injectable epinephrine. Authorizes the state health commissioner to issue a statewide standing order authorizing the dispensing of auto-injectable epinephrine. Extends certain immunities to the state department, the state health commissioner, and certain designated public health authorities. Requires the state department to approve courses concerning the administration of auto-injectable epinephrine. Requires a person to have successfully completed the course to be immune from civil liability. Adds exceptions to the requirement that controlled substance prescriptions be in an electronic format. Provides that the board of pharmacy, in consultation with the medical licensing board, may adopt emergency rules. Adds advanced practice registered nurses and physician assistants to the list of out-of-state providers whose prescriptions a pharmacist has a duty to honor. Allows a prescription for a patient to be transferred electronically or by facsimile by a pharmacy to another pharmacy if the pharmacies do not share a common data base. Allows a licensed pharmacy technician to transfer the prescription. Allows a pharmacist to substitute a therapeutic alternative for epinephrine products for a patient and to prescribe sterile water for injection with a prescription drug. Allows a pharmacy technician to administer an influenza immunization to an individual under a drug order or prescription, subject to rules adopted by the board of pharmacy. Provides that aggregated information compiled from annual reports of pharmacy benefit managers to the insurance commissioner is not confidential except for information that would reveal a specific pharmacy benefit manager's proprietary information. Requires: (1) a state employee health plan; and (2) an insurer-provided health plan that complies with the federal Affordable Care Act; to establish a procedure under which the amount paid by a covered individual for a covered prescription drug purchased outside of the health plan will offset the covered individual's deductible. Requires an insurer, when removing a prescription drug from the insurer's formulary or changing the cost sharing requirements applying to the prescription drug, to give an insured for whom the drug has been prescribed 60 days notice of the insurer's action and provide an appeal process through which the insured may request an extension of coverage for the drug through the end of the insured's plan year. us/states/in Indiana General Assembly 2020 HB 1207 Indiana HB 1207 (2020)
bill
PHARMACISTS AND PHARMACIES
HEALTH
State Department and Agencies
INSURANCE generally
enacted
John Ruckelshaus
Linda Rogers
Ronald Grooms
Steven Davisson
5 37 2 2020-01-16 2020-03-30 openstates ocd-bill/4e51d4c4-ec4d-4547-94e4-7709604e7e7d http://iga.in.gov/legislative/2020/bills/house/1207 0b53af48b1c0f2bd81dec7527117b7515a3233ca8bf7bf9145dec6e5a54b14f8 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-in

Indiana HB 1207 (2020) — Pharmacy matters.

Provides that a state employee plan, a health maintenance organization, an insurer, or a pharmacy benefits manager (health plan provider) may not require a pharmacy or pharmacist to collect a higher copayment for a prescription drug from a covered individual than the health plan provider allows the pharmacy or pharmacist to retain. Allows a pharmacist who meets certain requirements to dispense auto-injectable epinephrine by standing order to a person who: (1) has completed a course on auto-injectable epinephrine; and (2) is an individual in a position to assist an individual who is at risk of experiencing anaphylaxis. Allows a person to administer auto-injectable epinephrine to an individual who is experiencing anaphylaxis if certain conditions are met. Requires the state department of health (state department) to issue a statewide standing order authorizing the dispensing of auto-injectable epinephrine. Authorizes the state health commissioner to issue a statewide standing order authorizing the dispensing of auto-injectable epinephrine. Extends certain immunities to the state department, the state health commissioner, and certain designated public health authorities. Requires the state department to approve courses concerning the administration of auto-injectable epinephrine. Requires a person to have successfully completed the course to be immune from civil liability. Adds exceptions to the requirement that controlled substance prescriptions be in an electronic format. Provides that the board of pharmacy, in consultation with the medical licensing board, may adopt emergency rules. Adds advanced practice registered nurses and physician assistants to the list of out-of-state providers whose prescriptions a pharmacist has a duty to honor. Allows a prescription for a patient to be transferred electronically or by facsimile by a pharmacy to another pharmacy if the pharmacies do not share a common data base. Allows a licensed pharmacy technician to transfer the prescription. Allows a pharmacist to substitute a therapeutic alternative for epinephrine products for a patient and to prescribe sterile water for injection with a prescription drug. Allows a pharmacy technician to administer an influenza immunization to an individual under a drug order or prescription, subject to rules adopted by the board of pharmacy. Provides that aggregated information compiled from annual reports of pharmacy benefit managers to the insurance commissioner is not confidential except for information that would reveal a specific pharmacy benefit manager's proprietary information. Requires: (1) a state employee health plan; and (2) an insurer-provided health plan that complies with the federal Affordable Care Act; to establish a procedure under which the amount paid by a covered individual for a covered prescription drug purchased outside of the health plan will offset the covered individual's deductible. Requires an insurer, when removing a prescription drug from the insurer's formulary or changing the cost sharing requirements applying to the prescription drug, to give an insured for whom the drug has been prescribed 60 days notice of the insurer's action and provide an appeal process through which the insured may request an extension of coverage for the drug through the end of the insured's plan year.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Engrossed House Bill (H) (committee substitute) — source
  2. Enrolled House Bill (H) (committee substitute) — source
  3. House Bill (S) (committee substitute) — source
  4. House Bill (S) (committee substitute) — source
  5. Introduced House Bill (H) (committee substitute) — source

Votes

  • HB 1207 - Davisson - 3rd Reading — 980 (pass) · lower
  • HB 1207 - Grooms - 3rd Reading — 491 (pass) · upper

Sponsors

  • John Ruckelshaus — primary (person)
  • Linda Rogers — primary (person)
  • Ronald Grooms — primary (person)
  • Steven Davisson — primary (person)
  • Brad Barrett — coauthor (person)
  • James Buck — cosponsor (person)
  • Jean Leising — cosponsor (person)
  • Mike Bohacek — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2020-01-16 Authored by Representative Davisson
  • 2020-01-16 First reading: referred to Committee on Public Health reading-1, referral-committee
  • 2020-01-23 Committee report: amend do pass, adopted committee-passage
  • 2020-01-23 Representative Barrett added as coauthor
  • 2020-01-27 Second reading: ordered engrossed reading-2
  • 2020-01-28 Senate sponsors: Senators Grooms, Ruckelshaus, Rogers
  • 2020-01-28 Third reading: passed; Roll Call 94: yeas 98, nays 0 reading-3, passage
  • 2020-01-29 Referred to the Senate
  • 2020-02-05 First reading: referred to Committee on Health and Provider Services reading-1, referral-committee
  • 2020-02-13 Pursuant to Senate Rule 68(b); reassigned to Committee on Insurance and Financial Institutions referral-committee
  • 2020-02-20 Senator Bohacek added as cosponsor
  • 2020-02-27 Committee report: amend do pass, adopted committee-passage
  • 2020-03-02 Amendment #3 (Bohacek) prevailed; voice vote amendment-passage, amendment-failure
  • 2020-03-02 Amendment #1 (Ford J.D.) failed; Roll Call 264: yeas 10, nays 38 amendment-failure
  • 2020-03-02 Amendment #2 (Ford J.D.) failed; Roll Call 265: yeas 13, nays 36 amendment-failure
  • 2020-03-02 Second reading: amended, ordered engrossed reading-2
  • 2020-03-03 Third reading: passed; Roll Call 298: yeas 49, nays 1 reading-3, passage
  • 2020-03-03 Senator Buck added as cosponsor
  • 2020-03-03 Senator Leising added as cosponsor
  • 2020-03-04 Returned to the House with amendments amendment-failure
  • 2020-03-04 Motion to dissent filed
  • 2020-03-04 House dissented from Senate amendments amendment-failure
  • 2020-03-04 House conferees appointed: Davisson and Hatfield
  • 2020-03-04 House advisors appointed: Barrett, Lehman, Fleming and Shackleford
  • 2020-03-05 Senate conferees appointed: Bohacek and Mrvan
  • 2020-03-05 Senate advisors appointed: Ruckelshaus, Breaux, Grooms and Zay
  • 2020-03-11 Representative Davisson removed as conferee
  • 2020-03-11 Representative Clere added as conferee
  • 2020-03-11 CCR # 1 filed in the House
  • 2020-03-11 CCR # 1 filed in the Senate
  • 2020-03-11 Rules Suspended. Conference Committee Report 1: adopted by the Senate; Roll Call 399: yeas 47, nays 2
  • 2020-03-11 Rules Suspended. Conference Committee Report 1: adopted by the House; Roll Call 398: yeas 91, nays 0
  • 2020-03-12 Signed by the President Pro Tempore
  • 2020-03-16 Signed by the Speaker
  • 2020-03-18 Signed by the Governor executive-signature
  • 2020-03-18 Signed by the President of the Senate
  • 2020-03-30 Public Law 114

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/4e51d4c4-ec4d-4547-94e4-7709604e7e7d. Confidence: reported (aggregated from official Indiana legislature records).